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Introduction. Earlier reviews regarding the eﬀectiveness of Drug Treatment Courts (DTCs) reported a reduction in reoﬀending
and substance use. Although substance users suﬀer from other diﬃculties than drug use and judicial issues, none of these reviews
focused on outcomes or eﬀects of DTCs on drug-related life domains, such as social relationships, employment, or health.erefor,
the present paper aims to review the impact of adult DTCs on substance use and drug-related life domains.Method. Primary studies
were systematically searched inWeb of Knowledge. Observational and controlled evaluation studies of adult DTCs were considered
eligible if substance use and/or drug-related life domains were measured. Results. Moderately positive results were found with
respect to within-program substance use. Few studies used drug-related life domains as an outcome measure and most of them
yielded no eﬀects. Employment and family relations ameliorated when speci�c interventions were used. Discussion. DTCs yield
bene�cial outcomes and eﬀects regarding within-program substance use. However, evidence regarding the impact of DTCs on
post-program drug and alcohol use and on other drug-related life domains is scarce.ese life domains and thus QoL possibly can
be improved by DTCs if speci�cally targeted. Future research is warranted.
1. Introduction
Substance use disorders (SUDs) are important public health
problems inWestern countries [1, 2] and are oen regarded as
chronic relapsing disorders [3–6]. e chronicity of SUDs is
illustrated by the observation that most substance users cycle
repeatedly between abstinence on the one hand and relapses
into active substance use on the other hand before reaching
the phase of stable recovery. Sometimes stable recovery is
never reached [7]. In the past, lifelong abstinence was seen
as the only indicator of recovery. In recent years, however,
abstinence is seen as just one indicator of recovery. A shi
towards a focus on other life domains and quality of life (QoL)
as indicators for recovery from SUDs has been initiated [4, 8].
SUDs are typically associated with severe impairments in
drug-related life domains such as health, wellbeing, social
network, employment, and �nancial situation [3–6]. Diﬃ-
culties in these life domains remain for several years aer
abstinence has been achieved, particularly in the area of
employment [4]. Consequently, recovery from SUDs goes
beyond abstinence, instead all associated life domains should
be considered. Commitment to recovery is related to one’s
QoL which in its turn can be enhanced by (re)gaining and
maintaining certain desired needs in life (e.g., stable housing,
education and work, family, wellbeing, and stable �nancial
situation) [9–11].
Substance users are highly prevalent in the criminal
justice system [12, 13] due to substance-related oﬀences
(e.g., possession and/or consumption of drugs, driving while
intoxicated and the). Imposing judicial alternatives to
imprisonment on substance using oﬀenders contains an
opportunity to divert them to community (drug) treatment
services. ese alternative measures are associated with
improvements in drug-related life domains, next to decreases
in criminal oﬀending and substance use [14–16]. Generally,
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the initiation and maintenance of desistance from (drug-
related) crime should be accompanied by improvement in
several life domains, such as social network, employment,
and housing [17–19].
At court level, Drug Treatment Courts (DTCs) were
introduced to divert substance using oﬀenders to (drug)
treatment services [20]. Although DTCs diﬀer greatly with
respect to, amongst others, inclusion criteria, procedures,
treatment services, and treatment providers [21], some key
components can be distinguished: (1) alcohol and drug
treatment and rehabilitation services are present for partici-
pants, (2) a nonadversarial approach and an ongoing judicial
interaction with participants, (3) frequent alcohol and drug
testing, (4) rewarding or sanctioning according to partici-
pants’ compliance, (5) monitoring and evaluation of program
goals during multiple court hearings, and (6) partnerships
between drug court, public agencies, and community-based
organizations [22].
During the past decade, several reviews have been pub-
lished regarding the impact of DTCs on recidivism and sub-
stance use [21, 23–28]. In general, DTCs produce moderately
bene�cial results regarding recidivism, both during (within-
program) [21, 23–28] and aer (post-program) [23–25, 27,
28] the DTC program. ese favourable outcomes apply
for both drug-speci�c recidivism [25, 27, 28] and overall
recidivism [21, 25–28]. However, Wilson and colleagues [28]
concluded that DTCs have less impact on non-drug-related
oﬀences than on drug-related oﬀences.
With respect to substance use, results are less homoge-
nous. While the majority of reviewers concluded that sub-
stance use, as measured by drug tests, is to a certain extent
reduced in DTC participants (within-program) [21, 23–25],
Wilson and colleagues [28] found a negative eﬀect of DTCs
on substance use. In these review studies no information
was available regarding post-program urinalysis results, since
these tests are onlymandatory administeredwithin-program.
Only Brown [21] does not explicitly state that the presented
results are coming from within-program drug tests.
According to the GAO review [25], data on self-reported
substance use within-program are contradictory, and self-
reported substance use post-program did not signi�cantly
decrease. Mitchell and co-authors [27] also concluded that
substance use did not signi�cantly decline, but they did not
distinguish drug test results from self-reported substance use
nor within-program from post-program results.
None of the above-mentioned systematic reviews
reported data on the eﬀects of DTCs on drug-related
life domains. Although the National Association of Drug
Court Professionals [22, page 7] states that “while primarily
concerned with criminal activity and alcohol and other drugs
use, the drug court team also needs to consider co-occurring
problems such as mental illness,…, homelessness, basic
educational bene�ts, unemployment …, spouse and family
troubles.”
Obviously, improvement in drug-related life domains
plays an important role on the road to recovery and should
thus be considered when evaluating DTC outcomes since
these aim to reduce substance use and related criminal
oﬀending. However, previous reviews have not focused on
these drug-related life domains. erefore, the present paper
aims to review the impact ofDTCs on substance use andother
drug-related life domains.
2. Method
2.1. Inclusion Criteria. Studies on adult DTCs, namely,
standard “DTC”, “Family Treatment Drug Court” (FTDC),
“Dependency Drug Court” (DDC), “Driving Under In�u-
ence Court” (DUI), and “Driving While Intoxicated Court”
(DWI) were included. FTDCs (or DDCs) and DUIs (or
DWIs) are modeled on standard DTCs. e former are
aimed at substance abusing parents, the latter at substance
abusing drivers (especially drunk drivers). Observational
or controlled evaluation studies of DTCs were considered
eligible if at least one indicator of substance use and/or
drug-related life domains, analogous to the subscales of
the Addiction Severity Index (ASI; [29]) (namely, employ-
ment, �nancial situation, housing situation, physical and
mental health, family and social relationships, and leisure-
time activities), was reported as an outcome measure. No
restrictions regarding measurement method or instruments
were imposed.
2.2. Search Strategy and Study Selection. Web of Knowledge
was consulted twice using the following search terms and
Boolean operators up to December 31st, 2011: (1) a general
search using drug court AND (evaluation OR eﬀect∗ OR
outcome), and (2) a speci�c search using drug court AND
(employment OR work OR income OR �nancial OR housing
OR health OR family OR social OR leisure). e “title only”
option was marked and the search was restricted from 1989,
since the �rst DTC was implemented in this year [20].
e general and speci�c Web of Knowledge searches
together generated 576 hits. Aer removing double hits and
screening title and abstract, 61 potentially relevant papers
were retrieved for more detailed evaluation. ese studies
were screened on meeting the inclusion criteria and subse-
quently 45 studies were excluded aer reading the full texts
due to irrelevant subject, descriptive nature, a mere focus
on recidivism, or secondary analysis of previously published
data. Finally, 16 studies met the inclusion criteria, which are
[30–45] in the reference list of this paper.
2.3. Data Extraction. Eligible studies were independently
screened by two researchers (C. Wittouck and A. Dekkers)
using a checklist to extract data on the following variables:
(1) author, publication data, and country where the study was
conducted, (2) DTC characteristics and procedures, (3) study
design and follow-up period, (4) description of intervention
and control group (if present), (5) sample size and dropout
rate, (6) demographic and substance use characteristics of
participants, and (7) outcome variables, measurement instru-
ments, and study �ndings. Due to the heterogeneity in study
methodologies and the variety in data reporting, a narrative
review was regarded as most appropriate. e individual
study �ndings were grouped according to outcome measure
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andwere tabulated in a separate table to facilitate comparison
and discussion.
3. Results
3.1. Study Characteristics. Table 1 provides an overview of
included studies, according to location of DTC, study design,
participant characteristics, and outcome measures.
All but one study ([32], Australia) were conducted in the
USA. In half of the studies males were overrepresented (𝑛𝑛 𝑛
8) [30–32, 34, 35, 38, 39, 42]. In seven studies a larger number
of female participants was present [33, 37, 40, 41, 43–45].
e average age of participants is 31,29 years, with a
range from 24,37 [35] to 36,4 [45]. e participants are
predominantly Caucasian (range 23% to 78%) [32, 43],
African American (range 20% to 89%) [30, 34], or Hispanic
(range 16,1% to 85,5%) [36, 39].
3.2. Study Quality. Study quality was assessed using the
Maryland Scienti�c Methods Scale (MSMS) [46] and was
also based on the quality assessment criteria described in the
guidance for undertaking systematic reviews [47].
About half of the included studies (𝑛𝑛 𝑛 𝑛) were randomi-
zed controlled trials (RCT) [30, 34–36, 38, 42, 43]. ree
studies used a quasi-experimental design (QED) [33, 41, 44],
and two studies a noncontrolled pre-post design (PPD) [32,
45]. All studies, except the study of Brewster [31], speci�ed
which data collection tools were used. Oen used tools were
court �les, judicial databases, and interviews. Sample size was
mentioned in all studies, and ranged from 30 [42] to 3672
[37]. Ten studies indicated the dropout rate in their research
group(s) [30, 32, 34–36, 38–40, 43, 45] with a dropout rate
between 1,4% [30] over 28% [34] to 75% [32].
e follow-up period in the 16 included studies diﬀered
to a large extent. Some studies carried out a follow-up
measurement aer a particular time post-admission [36, 38,
41, 45]. Within these studies the follow-up period ranged
from four months aer baseline [45] up to three years aer
randomization [34]. In other studies, the outcomes were
measured on several follow-up moments, both within- and
post-program [30–32, 35, 39, 42, 43]. Some studies only
compare post-program outcomes [33, 34, 37, 40, 44].
3.3. Eﬀects on Drug Use, Alcohol Use, and Other Drug-Related
Life Domains. In Table 2 the individual study �ndings are
displayed according to study design and outcome measure.
Outcome measures were drug use, alcohol use, family and
social relationships, employment and income, and mental
and physical health. None of the included studies reported
on housing situation or leisure-time activities as outcome
measures. Five studies using a RCT [35, 36, 38, 42, 43] and
one study using a QED [41] were treated as observational
studies since they randomized between a standard DTC and
an “enhanced” DTC. Some studies only reported on post-
program outcomes regarding drug use and family reuni�ca-
tion but were still included in the review, since it could be
assumed that all participants were drug users at baseline or
risked losing parental rights at baseline [33, 34, 37, 40, 44].
Substance use signi�cantly improved over time in almost
all studies, regardless of study design. With respect to other
drug-related life domains, the diﬀerence in results between
observational studies and studies using a comparison con-
dition is very obvious. All observational studies, except
one [35], conclude that DTC participants improved on all
these drug-related life domains from pre- to post-test. ese
bene�cial results were not found by controlled studies. Most
of the latter types of studies only found favourable results for
DTCs on drug and alcohol use. Only FTDCs found bene�cial
results regarding family and social relationships.
3.3.1. Eﬀects on Drug Use. In the majority of the included
studies (𝑛𝑛 𝑛 𝑛𝑛, participants 𝑛𝑛 𝑛 𝑛𝑛𝑛𝑛) illicit drug use was an
outcome measure. In the Freeman study [32], illicit drug use
was measured indirectly by looking into self-reported weekly
spending. Weekly spending signi�cantly decreased while
weekly legal income did not change signi�cantly, indicating a
reduction in drug use over time. In the other studies drug use
was measured directly either by urine test results [30, 31, 42]
or self-reported data on drug use [34, 38, 45] or both [35, 39,
43].
Self-reported data on drug use showed positive results for
DTC participants within-program [35, 43, 45], at discharge
[39] and post-program [34, 35, 39, 43]. In addition, DTC
participants reported signi�cantly less illicit drug use than
drug using oﬀenders diverted to standard adjudication [34]
and methamphetamine-dependent outpatients with no drug
court supervision [39]. Leukefeld and colleagues [38] found
that drug use decreased for all study groups. However, the
study�s high upgrading group performed signi�cantly better
than the drug court as usual and the low upgrading group.
Urine test results also showed bene�cial outcomes for
DTC participants during the DTC trajectory [39, 42, 43].
Only one study reported on urine test results aer a DTC
program. Speci�cally, Dakof and colleagues [43] found that
mothers were less likely to provide a positive urine test
aer the DDC program ended. Deschenes et al. [30] found
that about half of DTC participants as well as probationers
delivered a positive drug test within-program. Signi�cant dif-
ferences between these two study groups emerged when type
of drugs was considered. Probationers tested signi�cantly
more positive for cocaine and heroin, whereas drug court
participants were signi�cantly more likely to test positive for
marijuana.
Not all studies concluded unanimously positive.
Although both DTC study groups in the Marlowe et al. study
[35] signi�cantly improved with respect to self-reported
drug problems, these results were not mirrored by the urine
drug screen results. Positive urine drug screens increased,
although not signi�cantly, over time for both conditions.
Most of these positive drug tests were related to cannabis
use. But then, the vast majority of study participants were
cannabis users at baseline. Brewster [31] found that, although
the rate of positive drug tests was lower for DTC participants
in comparison with probation participants, a comparable
amount of participants from both study groups remained
drug-free throughout the study period. Possibly, the higher
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T 2: Individual study �ndings according to study design and outcomes measure∗.
Drug use Alcohol use Family(and social) relationships Employment Income Mental health Physical health
PPD1
Johnson et al. (2011) [45] + # # # # # #
Freeman (2003) [32] + # + # # + +
RCT2 or QED3 treated as PPD
Dakof et al. (2010) [43] + + + + + +
Dakof et al. (2009) [41] # # + # # # #
Marlowe et al. (2009) [42] + # # # # # #
Leukefeld et al. (2007) [38] + + # + + # #
Eibner et al. (2006) [36] + # # # # #
Marlowe et al. (2005) [35] + (−) + = = = +
QED
Burrus et al. (2011) [44] # # + # # # #
Worcel et al. (2008) [40] # # + # # # #
Marinelli-casey et al. (2008)
[39] + = = = = =
Boles et al. (2007) [37] # # + # # # #
Ashford (2004) [33] # # = # # # #
Brewster (2001) [31] = # # = # # #
RCT
Gottfredson et al. (2005) [34] + + = = + = =
Deschenes et al. (1995) [30] + # # − # # #
∗
A “+” indicates a signi�cant diﬀerence in favor of the DTC, a “−” indicates a signi�cant diﬀerence in favor of the control group, a “�” indicates no signi�cant
diﬀerence between the DTC and the control group, and “#” indicates that the outcome variable was not reported.
1non-controlled pre-post design.
2randomized controlled trial.
3quasi-experimental design.
amount of positive drug tests among probationers can be
attributed to drug testing at irregular intervals (e.g. in case of
suspicion) of drug use), while testing of DTC participants at
regular intervals is standard practice.
3.3.2. Eﬀects on Alcohol Use. Only six studies (participants
𝑛𝑛 𝑛 𝑛𝑛𝑛𝑛) included alcohol use as an outcome measure. Eib-
ner and colleagues [36] focused exclusively on alcohol use
since they evaluated a DUI court. All six studies found
that DTC participants reported signi�cantly less alcohol use
over time. DTC participants as well as outpatients with no
DTC supervision, both suﬀering from methamphetamine
dependence, reported signi�cantly less alcohol use over time
[39].
3.3.3. Eﬀects on Family and Social Relationships. In ten of the
included studies (participants 𝑛𝑛 𝑛 𝑛2𝑛𝑛) family and social
relationships were used as an outcome measure. While in
some studies social functioning [32], family functioning,
and parenting practices [41, 43] of DTC participants signi�-
cantly improved over time, other studies found no diﬀerence
regarding family and social relationships [35].
In comparison with non-DTC methamphetamine-
dependent outpatients [39] and drug using oﬀenders proc-
essed through standard adjudication [34], family and social
relations of DTC participants improved signi�cantly.
Slightly more than half (𝑛𝑛 𝑛 𝑛, participants 𝑛𝑛 𝑛 𝑛𝑛𝑛2)
of these ten studies evaluated FTDC [33, 37, 40, 41, 43, 44].
Dakof and colleagues [41, 43] found that FTDC interventions
can positively in�uence child welfare outcomes. Besides, at
follow-up, family reuni�cation was signi�cantly more likely
in FTDC cases than in cases processed through traditional
child welfare services [37, 40, 44], except in the Ashford
study [33]. Children of parents managed by traditional child
welfare services were signi�cantly more likely to be allocated
to out-of-home-placement [37] and to reach permanency
faster [40, 44]. Ashford [33], on the other hand, found that
FTDC children reached a permanency decision sooner than
children in traditional child welfare services. Furthermore,
time to family reuni�cation was signi�cantly longer for
children in traditional child welfare services than children
in the FTDC group [40]. In addition, Burrus and colleagues
[44] found that FTDC children spent less time in nonkinship
foster care. Surprisingly, Boles and colleagues [37] also found
that DDC participants had a higher re-entry rate to out-of-
home care a�er family reuni�cation than comparison partic-
ipants. When outcomes of these re-entries were examined,
however, it was found that all these comparison children
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moved to permanency, while almost one third of DDC
children were subsequently reuni�ed with their parents.
3.3.4. Eﬀects on Employment and Income. About half of the
included studies (𝑛𝑛 𝑛 𝑛, participants 𝑛𝑛 𝑛 𝑛𝑛𝑛𝑛) used employ-
ment as an outcome measure, and two of these studies
also reported on income. Only two studies found bene�cial
outcomes for DTC participants regarding employment sit-
uation. Dakof and co-authors [43] found that employment
problems of mothers in DDC signi�cantly decreased. In
their evaluation of an enhanced employment intervention,
Leukefeld and colleagues [38] found that high upgrading par-
ticipants reported signi�cantly more full-time employment,
signi�cantly less unemployment, and more days of working
when compared to both the no-intervention and the low
upgrading group. Participants in the no-intervention group
worked signi�cantly more in the past 30 days than those in
the low upgrading group. In concordance with the above-
mentioned results, participants in the high upgrading group
reported more income from a legitimate job in the past year
than those in the low upgrading group. e no-intervention
group did not diﬀer from either of the upgrading groups.
In the Marlowe et al. [35] study, reported employment
problemswere not signi�cantly reduced over time for partici-
pants from both DTC conditions. Furthermore, employment
situation of drug court participants did not diﬀer signi�-
cantly when compared to non-drug court participants with
methamphetamine dependence [39], standard adjudication
[34], and probationers [31]. Deschenes and colleagues [30]
even concluded that probationers were signi�cantly more
likely to be employed than drug court participants. How-
ever, during the follow-up period, DTC participants were
signi�cantly more likely than probationers to be involved in
counselling and outpatient treatment sessions [30]. Although
Gottfredson and co-authors [34] did not �nd a signi�cant
diﬀerence regarding employment situation between drug
court participants and drug oﬀenders processed through
traditional adjudication, they did �nd the former relying on
welfare signi�cantly less than the latter, which could be due
to a reduction in money spent on drug use since drug use
decreased signi�cantly in DTC participants.
3.3.5. Eﬀects on Mental and Physical Health. In only �ve
studies (participants 𝑛𝑛 𝑛 𝑛𝑛𝑛) the eﬀects of drug treatment
court on mental and physical health was examined. Mental
health [32, 43], general health and vitality [32] of DTC
participants signi�cantly increased over time, while medical
problems [35, 43], bodily pain, and emotional and physical
role limits [32] of DTC participants signi�cantly decreased
over time.Marlowe and colleagues [35], however, did not �nd
improvement for mental health and Freeman [32] found no
improvement regarding physical functioning.
Furthermore, no diﬀerences were found regarding men-
tal and physical health between DTC participants and non-
DTC methamphetamine-dependent outpatients [39] nor
between DCT participants and drug using oﬀenders pro-
cessed through standard adjudication [34].
4. Discussion
e results of the present paper show that, in general,
DTCs appear to produce a decrease of illicit drug use in
substance using oﬀenders during a DTC trajectory, which
was also found by earlier review studies [21, 23–25]. DTC
participants, who did not reach abstinence, oenmoved away
from more harmful substances as heroin to less harmful
substances as marijuana [30]. Little information is currently
available on the long-term eﬀects of DTCs on illicit drug
use. Although long-term self-report data show promising
results, information from urinalysis con�rming these results
is lacking. Alcohol use of DTC participants also decreased.
Surprisingly alcohol use was an outcome measure in only
half of the included studies, given the well-established link
between drug and alcohol use [48–51].
Although the importance of drug-related life domains,
for example employment and housing, is recognized in the
recovery and desistance literature [9–11, 14, 15, 17–19],
only a small amount of DTC evaluation studies focusing
on these outcomes were found. e lack of empirical data
on the eﬀects of DTCs on drug-related life domains might
be explained in two ways. Or DTCs focus predominantly
on substance use and drug-related crime which results in a
lack of attention to other drug-related life domains. Or DTC
research has not yet caught up with the state of the art on
recovery, resulting in a lack of focus on these drug-related
life domains. Consequently, DTC research should broaden
its focus and systematically record information on DTC
interventions aimed at these drug-related life domains, and
study the short-term and long-term eﬀects of DTCs on these
life domains and QoL of DTC participants. Subsequently,
evidence-based recommendations can be made in order to
improve DTC policy and practice.
As for the studies that do focus on drug-related life
domains, observational studies found bene�cial results,
which were not consistently demonstrated by (randomized)
controlled studies. As opposed to standard adult DTCs,
FTDCs do appear to positively in�uence child welfare
outcomes (e.g., family reuni�cation) [37, 40, 44]. Next,
Leukefeld and colleagues [38] found that DTC participants
who received an enhanced employment intervention aimed
at obtaining, maintaining, and upgrading employment and
attended su�cient sessions, had more bene�cial outcomes
regarding their work situation (e.g., more full-time employ-
ment and less unemployment).
Following the (moderately) positive results of DTCs on
substance use, of FTDCs on child welfare outcomes and of
the DTC with an enhanced employment intervention on
work situation, it can be hypothesized that providing speci�c
interventions for each of the drug-related life domains will
bene�cially aﬀect these domains. Indeed, considering the
chronicity of SUDs and the complexity of associated prob-
lems [3–7], one cannot expect that a mere focus on substance
use as such will automatically entail improvements in other
life domains. Moreover, by oﬀering interventions speci�cally
aimed at improving drug-related life domains, attention is
given to outcomes which are reported as desired by drug
users themselves. In other words, such interventions start
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from drugs users’ own experiences and expectations (e.g.,
QoL) [52]. Aer all, the recovery model is a widely used and
accepted approach for supporting persons withmental health
and/or addiction problems, ultimately aimed at improving
QoL [9, 53, 54]. When substance users experience progress
in those drug-related life domains they consider important,
and subsequently in their QoL, their drug use and criminal
oﬀending could be positively in�uenced.
No information was available regarding the eﬀects
of DTCs on housing situation or leisure-time activities,
although research shows that moving away from drug-
using friends and acquaintances supports the maintenance of
abstinence [17] and permanent housing is associated with a
reduction in recidivism [14, 15]. In addition, non-substance-
related leisure-time activities contribute to a higherQoL [55].
Some limitations of the present paper should be
addressed. First, one should be cautious when generalizing
the results of the present paper. e restriction of the
search strategy to peer reviewed publications could have
induced publication bias, since oen only favorable results
are published. Although peer review also guarantees some
form of quality control. Mitchell and colleagues [27, p. 69]
also found that the results of published and unpublished
studies on the eﬀects of DTCs are “roughly similar.” Next,
only a small number of individual studies reporting on
the eﬀects of DTCs on drug use, alcohol use, and/or
drug-related life domains were available. e included
studies are also marked with substantial heterogeneity
regarding methodology, sample size, and measurement
instruments. Comparability of individual study results is
further compromised since comparability between DTCs
from diﬀerent jurisdictions is low (e.g., inclusion criteria,
procedures, treatment services, and treatment providers)
[21]. Evaluations are thus very site-speci�c, which gives little
insight into the overall eﬀectiveness of the system [56]. In
fact, a general DTC framework and general DTC theoretical
underpinnings are lacking [56, 57]. Generalizability is
further limited since bene�cial outcomes are more prevalent
in DTC graduates than in dropouts [25, 27], and in general
about half of DTC participants drop out of the trajectory
[21, 23–25]. e dropout rate varied greatly between the
included studies, and intent-to-treat analyses were not
carried out or were impossible to carry out. In addition, the
included studies were almost exclusively USA based. e
adoption of USA DTC practices and the generalizability of
USA DTC results to other countries, especially European,
is problematic because of fundamental diﬀerences in the
law system. Second, RCTs, which receive the highest score
on the Maryland Scienti�c Methods Scale [46], are rare in
evaluating DTC’s eﬀectiveness. In the present review less
than half of the 16 included studies used a RCT, and only
two of these RCTs randomly assigned participants to DTC
or another kind of judicial processing.e observational and
quasi-experimental studies do not allow to conclude that the
observed bene�cial outcomes are attributable to DTCs, since
improvement due to confounding factors cannot be ruled
out. Finally, to our knowledge, the longest follow-up period
in DTC evaluation studies is three years [34]. Empirical
data on the long-term eﬀects of DTCs on drug-related life
domains and substance use (and criminal oﬀending) is thus
lacking since studies with extended follow-up periods are
non-existent.
To conclude, although one should consider the above-
mentioned limitations when generalizing the present paper’s
results, some important conclusions should be highlighted.
First, through a dominant focus on substance use and
criminal oﬀending, DTCs and DTC research possibly suﬀer
from a lack of attention and interest for other drug-related
life domains and QoL of substance users. Second, these life
domains can be improved as long as they are addressed.
Consequently, DTC policy and practice should be adapted
according to the recent �ndings of recovery and desistance
research by focusing on improvement in drug-related life
domains and by targeting these domains using speci�c inter-
ventions thus improving QoL of substance using oﬀenders.
In addition, each DTC trajectory should be tailored to the
unique problems a DTC client faces, herewith assuring a
more individual approach. As research has shown that great
interpersonal variability exists between DTC participants,
and that the eﬀectiveness of DTCs diﬀers according to these
diﬀerences [38, 58, 59]. Finally, it can be expected that a
decrease in substance use and criminal oﬀending results from
better life circumstances for substance users. erefor, future
research on the eﬀectiveness of DTCs should use a more
comprehensive focus and study the short-term and long-term
eﬀects of DTCs on drug-related life domains and QoL next
to the eﬀects on substance use and criminal oﬀending, which
are, aer all, socially desirable outcomes [52].
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